サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701982

エアロゾルデリバリーデバイス市場：製品別、用途別、流通チャネル別、地域別、2025-2033年

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
エアロゾルデリバリーデバイス市場：製品別、用途別、流通チャネル別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エアロゾルデリバリーデバイス市場の世界市場規模は2024年に495億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに752億米ドルに達し、2025年から2033年の間に4.8％の成長率（CAGR）を示すと予測しています。この市場は主に、呼吸器疾患の発生率の上昇、吸入技術の向上、老人人口の増加、ヘルスケアコストの上昇、カスタマイズされた医薬品の利用可能性に関する世界の意識の高まりによって牽引されています。

エアロゾルデリバリーデバイスは、喘息、閉塞性肺疾患、嚢胞性線維症、肺動脈性肺高血圧症、感染性肺疾患などの呼吸器疾患の治療や薬物送達に使用されます。エアロゾルは投与量を減らし、全身的な副作用を軽減し、患者の自己投薬能力を向上させる。一般的に利用可能なエアロゾル送達装置には、加圧式定量吸入器、ネブライザー、バルブ付きホルダーチャンバーなどがあります。現在、スマートエアロゾルドラッグデリバリーデバイスは、新規高分子医薬品の出現により、糖尿病、鎮痛、甲状腺疾患、遺伝性疾患など、呼吸器系以外の疾患にも使用されています。

エアロゾルデリバリーデバイス市場動向：

患者の急性呼吸器感染症を引き起こすコロナウイルス病（COVID-19）の世界的流行は、エアロゾルデリバリーデバイスの必要性を高める重要な要因の一つです。これらのデバイスは、家庭やヘルスケア環境での閉塞性気道疾患の治療を支援します。これとは別に、急増する大気汚染レベル、アレルゲン、職業上のリスクによる慢性呼吸器感染症の有病率の上昇、タバコを吸う人や飲酒する人の増加が市場の成長を促進しています。さらに、深刻な健康疾患を開発しやすい老年人口の大幅な増加が、便利で経済的な携帯用吸入装置の需要にプラスの影響を与えています。これに加え、新興国市場のプレーヤーは、肺の慢性炎症や感染症の治療に役立ち、嚢胞性線維症（CF）患者の気道クリアランスを改善する新しいエアロゾル送達装置を開発しています。さらに、eコマースチャネルを通じて、自動記憶機能を持ち、旅行中でも使いやすい小型超音波ネブライザーや吸入器を提供しています。これは、個別化された薬物療法に対する需要の高まりや、医療用品購入のためのオンラインチャネルの利用の増加と相まって、市場を牽引しています。

本レポートで扱う主な質問

  • 2024年の世界のエアロゾルデリバリーデバイス市場の市場規模は？
  • 2025-2033年の世界のエアロゾルデリバリーデバイス市場の予想成長率は？
  • 世界のエアロゾルデリバリーデバイス市場を牽引する主要因は何か？
  • 世界のエアロゾルデリバリーデバイス市場に対するCOVID-19の影響は？
  • 世界のエアロゾルデリバリーデバイス市場の製品別内訳は？
  • 世界のエアロゾルデリバリーデバイス市場の流通チャネル別内訳は？
  • 世界のエアロゾルデリバリーデバイス市場における主要地域は？
  • 世界のエアロゾルデリバリーデバイス市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のエアロゾルデリバリーデバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • ドライパウダー吸入器
    • 主要セグメント
      • 単回
      • 複数回
  • 定量噴霧吸入器
    • 主要セグメント
      • 従来型加圧吸入器
      • ソフトミスト吸入器
  • ネブライザー
    • 主要セグメント
      • ジェットネブライザー
      • 超音波ネブライザー
      • 振動メッシュネブライザー

第7章 市場内訳：用途別

  • 喘息
  • 慢性閉塞性肺疾患（COPD）
  • 嚢胞性線維症
  • 非呼吸器疾患
    • 主要セグメント
      • 糖尿病
      • 鎮痛
      • パーキンソン病

第8章 市場内訳：流通チャネル別

  • 小売薬局
  • 病院薬局
  • オンラインストア

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Aerogen
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Koninklijke Philips N.V.
    • Merck & Co. Inc.
    • Metall Zug AG
    • Recipharm AB（publ）
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
図表

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players
目次
Product Code: SR112025A4892

The global aerosol delivery devices market size reached USD 49.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 75.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is primarily driven by the rising rates of respiratory illnesses, improvements in inhalation technology, growing geriatric population, rising healthcare costs, and a growing global awareness regarding the availability of customized medicine.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

Breakup by Product:

  • Dry Powder Inhalers
  • Single Dose Inhalers
  • Multi Dose Inhalers
  • Metered Dose Inhalers
  • Conventional Pressurized Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Jet Nebulizers
  • Ultrasonic Wave Nebulizers
  • Vibrating Mesh Nebulizers

Breakup by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
  • Diabetes
  • Analgesia
  • Parkinson's Disease

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1.What was the size of the global aerosol delivery devices market in 2024?
  • 2.What is the expected growth rate of the global aerosol delivery devices market during 2025-2033?
  • 3.What are the key factors driving the global aerosol delivery devices market?
  • 4.What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5.What is the breakup of the global aerosol delivery devices market based on the product?
  • 6.What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7.What are the key regions in the global aerosol delivery devices market?
  • 8.Who are the key players/companies in the global aerosol delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis